Buff....as well as looking at the differences in the two devices (mentioned above), you should take a look at EMV's involvement with the ASA. I have provided a link to the original ASX announcement below. The ASA's influence in Australia cannot be underestimated. It is headed by Professors Stephen Davis & Geoffrey Donnan, both very well credentialed and respected experts in the world of stroke. They are also both on EMV's Clinical Advisory Board. IMO, this is a huge tick of confidence for EMV. As always DYOR.
https://www.listcorp.com/asx/emv/emvision-medical-devices-limited/news/asa-and-amp-emvision-sign-8m-project-agreement-2593509.html
https://austrokealliance.org.au
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.80 |
Change
0.000(0.00%) |
Mkt cap ! $153.5M | |||
| Open | High | Low | Value | Volume |
| $1.80 | $1.81 | $1.77 | $88.77K | 49.72K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 876 | $1.78 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.80 | 3875 | 1 |
View Market Depth
| Last trade - 14.41pm 27/06/2025 (20 minute delay) ? |
| EMV (ASX) Chart |